TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 315 filers reported holding TANDEM DIABETES CARE INC in Q4 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $588 | -14.9% | 28,293 | +0.5% | 0.00% | -25.0% |
| Q2 2023 | $691 | -39.0% | 28,153 | +0.9% | 0.00% | -33.3% |
| Q1 2023 | $1,133 | -9.0% | 27,893 | +0.7% | 0.01% | -25.0% |
| Q4 2022 | $1,245 | -99.9% | 27,693 | +1.3% | 0.01% | -11.1% |
| Q3 2022 | $1,308,000 | -18.1% | 27,343 | +1.3% | 0.01% | -10.0% |
| Q2 2022 | $1,598,000 | -39.7% | 26,993 | +18.4% | 0.01% | -33.3% |
| Q1 2022 | $2,652,000 | -21.5% | 22,802 | +1.6% | 0.02% | -16.7% |
| Q4 2021 | $3,378,000 | +28.7% | 22,439 | +2.1% | 0.02% | +20.0% |
| Q3 2021 | $2,624,000 | +26.8% | 21,979 | +3.5% | 0.02% | +25.0% |
| Q2 2021 | $2,069,000 | +5.6% | 21,240 | -4.3% | 0.01% | 0.0% |
| Q1 2021 | $1,959,000 | -8.0% | 22,200 | -0.2% | 0.01% | -14.3% |
| Q4 2020 | $2,129,000 | -13.7% | 22,250 | +2.3% | 0.01% | -26.3% |
| Q3 2020 | $2,467,000 | +16.1% | 21,740 | +1.3% | 0.02% | +5.6% |
| Q2 2020 | $2,124,000 | – | 21,470 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |